| Medicine home | About | Future students | Current students | Research | Alumni | Contact us |
| Staff (Intranet) | Staff directory | A-Z index | Site map |
|
|
Haemostasis Registry
The Haemostasis Registry was established in February 2005 at the Department of Epidemiology and Preventive medicine. The purpose of this registry is to gain information on safety, efficacy and appropriateness of use and dosages of recombinant activated factor VII (rFVIIa, NovoSeven) where it is used for non-haemophiliac patients. Establishment of a register will provide valuable observational data including efficacy, adverse events, effective dosage and cost-effectiveness. This data will be of substantial value in the development of prospective trials. The registry is supported by an educational grant from Novo Nordisk. Steering CommitteeProfessor James Isbister (Chair) Investigators Workshop May 2009 |